Excelsior Correspondent
JAMMU, Jan 2: The CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu, released its Annual Work Report for 2024-25 and unveiled its roadmap for 2026 during an event organised to mark the New Year. The official calendar for 2026 was also released on the occasion.
Director, CSIR-IIIM Jammu, Dr. Zabeer Ahmed, presided over the event and highlighted the institute’s scientific achievements, societal contributions, infrastructure development, and future priorities, in alignment with the vision of CSIR leadership.
Presenting the Annual Work Report, Dr Ahmed described 2025 as a year of robust scientific output, institutional strengthening, and impactful societal engagement.
“CSIR-IIIM filed 09 Indian and 19 foreign patents during the year and published 173 peer-reviewed research papers, reinforcing its position as a leading research institution. The institute also awarded 69 PhD degrees, underscoring its growing role as a premier research and academic hub,” he said.
Building on the momentum, Dr. Ahmed outlined a clear and ambitious agenda for 2026.
In the area of drug discovery, he said the institute plans to initiate Phase I/II clinical trials for its pancreatic cancer drug IIIM-290 and would put its efforts to file at least one US FDA application for a phytopharmaceutical lead.
“Efforts will also focus on advancing technologies committed for transfer by 2030 while expanding the drug development pipeline,” he said.
For societal missions, CSIR-IIIM is preparing for Aroma Mission Phase-IV and Floriculture Mission Phase-III, with sharper farmer-centric verticals, stronger market linkages, and enhanced income generation.
“The institute also aims to shift towards job-oriented skill development programmes and provide advanced incubation support through TBI, BioNEST, and AIC centres, strengthening the regional startup ecosystem,” Director CSIR-IIIM Jammu said.
Among those present on the occasion were Chief Scientists- Abdul Rahim, Head, RMBD&IST Division and IIIM Branch Srinagar; Dr Asha Chaubey, Head, Fermentation and Microbial Biotechnology Division; and Dr Shashank Kr Singh; Senior Principal Scientists-Dr. Dhiraj Vyas, Head, Plant Sciences and Agrotechnology Division; Dr Sumit G Gandhi, Head, Infectious Diseases Division; Dr Tasduq Abdullah; Dr Suphla B Gupta; Dr Amit Nargotra; and Dr Saurabh Saran; Principal Scientist-Dr Nasir ul Rasheed; and Administrative Officer-Rajesh Gupta. The proceedings concluded with a vote of thanks presented by Rajesh Gupta.
The post IIIM Jammu releases 2024-25 Annual Report, unveils roadmap for 2026 appeared first on Daily Excelsior.